5 Stocks Where Promoters are Boosting Their Stakes

Ever wondered why savvy investors monitor companies with rising promoter holdings?

Tracking the promoters' change in holdings can be a game-changer for your investment strategy.

When promoters increase their stake, it demonstrates their confidence in the company's future growth and long-term prospects.

Promoters are typically the founders or key players who have an intimate understanding of the business and its long-term strategy.

Their decision to invest more of their own money into the company can indicate a belief in its potential to outperform in both the short and long term.

Their increased holdings can signal strong fundamentals and stability, making it a useful indicator for retail investors to follow.

A rise in promoter holdings often suggests they are confident in navigating market challenges and also willing to put their own capital at risk, which can be a strong signal for investors.

This commitment may also reflect a long-term growth strategy, especially if it happens during market downturns, when prices are low.

Monitoring this provides valuable insight into the company's outlook, helping investors align their portfolios with firms that have strong leadership and a clear vision for the future.

In this context, we will be looking at some companies that have experienced an increase in promoters' holdings.

Let's delve into each of these companies in more detail...

#1 India Cements

First on the list is India Cements.

India Cements is the largest producer of cement in South India.

The company has four plants in Tamil Nadu and four in Andhra Pradesh catering to South India and Maharashtra. It's a market leader with a share of 28% in the South India.

It has a distribution network with over 10,000 stockists. Its brands include Coromandel King, Sankar Sakthi, Raasi Gold Coromandel blended cements and sulphate resisting portland cement. Its product also includes ready mix concrete (RMC).

Coming to its financials, the company reported a decrease in sales of 15.4% YoY to Rs 9.4 bn, in December quarter of FY25.

The gross profit margin for the quarter stood at 74.8%, down from 79.5%, in Q3 FY24.

At the operating level, the company reported a loss of Rs 1.9 bn. Due to other income of Rs 3.9 bn, it managed to report a net profit of Rs 1.2 bn. The net profit margin for the quarter stood at 12.6%, versus 0.1%, in Q3 FY24.

India Cements Snapshot (2020-24)

	FY20	FY21	FY22	FY23	FY24
Revenue Growth (%)	-10%	-13%	8%	15%	-9%
Gross Profit Margin (%)	81%	82%	83%	80%	79%
Operating Profit Margin (%)	12%	18%	10%	NM	2%
Net Profit Margin (%)	1%	5%	2%	NM	NM
Return on Capital Employed (%)	4%	7%	3%	NM	NM
Return on Equity (%)	1%	4%	1%	NM	NM

Data Source: Ace Equity

During the quarter, there was a massive increase in the promoter holdings to 55.5%, versus 28.4%, in Q2 FY25, reflecting high management confidence in the business.

India Cements' management is optimistic about its future. The company foresees robust demand in the South India, where capacity is deemed sufficient to meet market requirements.

India's cement consumption is projected to grow significantly due to ongoing infrastructure projects and investments in housing and commercial developments.

To know more about the company, check out its financial factsheet and latest quarterly results.

#2 UPL

Next on this list is UPL.

UPL is engaged in agrochemicals, industrial chemicals, chemical intermediates, specialty chemicals, and the production of field crops and vegetable seeds.

The company is a leading provider of agricultural solutions and services, with 14,236 registered products, 1,884 patents granted across the globe, a presence in around 140 countries, and access to 90% of the world's food basket.

UPL's products include crop protection chemicals like insecticides, fungicides, herbicides, seeds, and bio-solutions. It's the fifth largest agrochemical company globally with forty-three manufacturing facilities.

Its agritech platform 'Nurture' connects with around 3 million (m) registered farmers, 85,000+ retailers, and 25,000 dealers.

Coming to its financial performance, the company reported an increase in sales of 9% YoY to Rs 110.9 bn in September FY25 quarter.

The gross profit margin during the quarter stood at 47%, versus 49%, in Q2 FY24.

The operating profit for the quarter stood at 12.1 bn, a slight increase versus Q2 FY24. The operating profit margin for the quarter remained flat at 11%.

At the net level, the company saw a loss of Rs 5.8 bn, versus a loss of 2.9 bn, in Q2 FY24.

UPL Snapshot (2020-24)

	FY20	FY21	FY22	FY23	FY24
Revenue Growth (%)	64%	8%	20%	16%	-20%
Gross Profit Margin (%)	48%	51%	52%	49%	43%
Operating Profit Margin (%)	19%	22%	21%	19%	10%
Net Profit Margin (%)	6%	9%	10%	8%	NM
Return on Capital Employed (%)	10%	13%	14%	14%	3%
Return on Equity (%)	11%	17%	18%	16%	NM

Data Source: Ace Equity

Recently, the company's promoters announced an increase in their stake in the company from 32.5% to 33.5%, compared to the previous quarter.

The management expects margin accretion in Q3 and the full year FY25, driven by stable prices for key active ingredients, lower input costs, improved product mix, and market share growth.

It has given guidance for FY25, which includes revenue growth of 4% to 8% and an operating profit growth of over 50%.

The management is confident of improved profit margins in the second half of the year, supported by fresh inventory at lower costs and increasing sales of differentiated products.

To know more about the company, you can check out its financial factsheet and quarterly results.

#3 Mold Tek Packaging

Next on the list is Mold Tek Packaging.

Mold-Tek Packaging Limited (MTPL) is engaged in the manufacturing of injection-molded containers for lubes, paints, food, and other products.

It is a leader in rigid plastic packaging in India. It manufactures injection molded containers for lubes, paints, food, and other products.

Its customers include Himalaya, Kansai Nerolac Paints Limited, Asian Paints, Castrol, Mondelez International, Kwality Walls, Dabur, Adani Wilmar, Nescafe, Amul, P&G, Haldiram's, etc.

Coming to its financials, Mold Tek Packaging has reported revenue of Rs 1.9 bn, up 12.3% YoY for the September FY25 quarter with 6.9% YoY growth in the sales volumes.

Operating profit came at Rs 336 m, up a modest 4.4% YoY due to a shift in the product mix, and less than optimum utilisation of newly added capacities.

The operating margin came in at 17.6% vs 18.9% YoY. Higher depreciation and interest expense amid significant investments in last 2 years led to net profit of Rs 141 m, down 10.1% YoY with a net margin of 7.4% vs 9.4% YoY.

Mold Tek Packaging Snapshot (2020-24)

	FY20	FY21	FY22	FY23	FY24
Revenue Growth (%)	11%	9%	32%	16%	-4%
Gross Profit Margin (%)	53%	52%	49%	49%	52%
Operating Profit Margin (%)	18%	20%	19%	19%	19%
Net Profit Margin (%)	9%	10%	10%	11%	10%
Return on Capital Employed (%)	21%	22%	22%	19%	14%
Return on Equity (%)	19%	19%	14%	14%	11%

Data Source: Ace Equity

Recently, the promoters of Mold Tek Packaging increased their stake in the company to 32.9%, up from 32.7% in the previous quarter.

Going ahead, the management remains optimistic about future growth, particularly in the pharma segment, citing strong demand and approvals from major clients.

They anticipate operational improvements and better financial performance in H2 FY25 compared to H1.

The management anticipates double-digit growth for the full year, though initial targets of 15% may not be achievable due to delays in the Mahad plant's operations and the printing facility's expansion.

To know more about the company, check out the company factsheet and latest quarterly results.

#4 Himadri Speciality Chemical

Next in the list is Himadri Speciality Chemical.

Himadri Speciality Chemical Ltd (HSCL) is primarily engaged in the manufacturing of carbon materials and chemicals.

It is the top coal pitch manufacturer in India and is the only company to manufacture advanced carbon materials in India.

The company is a key player across various product segments, including battery materials, coal tar pitch, carbon black, naphthalene, refined naphthalene, SNF, and specialty oils.

HSCL serves a diverse range of industries, such as lithium-ion batteries, paints, plastics, tires, aluminium, graphite electrodes, agrochemicals, defence, and construction chemicals.

Coming to its financials, the company reported an increase in sales of 8.4% YoY to Rs 11.4 bn, in Q3 FY25. The gross margin increased to 33% versus 28%, in Q3 FY24.

At the operating level, the company has managed to achieve a profit of 2.2 bn. The operating profit margin of the quarter stood at 19%, versus 17%, YoY.

The net profit for the quarter stood at Rs 1.4 bn. The net margin on the other hand increased to 12.4% versus 10.3%, YoY.

Himadri Speciality Chemical Snapshot (2020-24)

	FY20	FY21	FY22	FY23	FY24
Revenue Growth (%)	-25%	-7%	66%	49%	0.30%
Gross Profit Margin (%)	32%	27%	20%	22%	28%
Operating Profit Margin (%)	16%	8%	6%	10%	15%
Net Profit Margin (%)	11%	3%	1%	5%	10%
Return on Capital Employed (%)	11%	4%	5%	13%	19%
Return on Equity (%)	12%	3%	2%	9%	14%

Data Source: Ace Equity

In the third quarter of FY25, promoter holdings increase from 50.7% to 51.5%.

The management is optimistic about the future on the back of lithium ion battery demand growing 33% annually and battery energy storage demand also poised to grow multifold.

To know more about the company check out its financial factsheet and quarterly results.

#5 IOL Chemicals & Pharmaceuticals

Next in the list is IOL Chemicals & Pharmaceuticals.

IOL Chemicals & Pharmaceuticals is a leading pharmaceutical (APIs) company and is a significant player in the specialty chemicals space. It serves the domestic and export market.

It is the largest player of Ibuprofen (pain killer) globally with a world market share of 35% (12,000 TPA) with backward integration.

It is the largest producer of Ethyl Acetate at single location in India and also 2nd largest producer of Iso Butyl Benzene (IBB) with 30% global share.

Coming to its financials, the company h3>sales decreased 3.6% YoY to Rs 5.3 bn, in the September quarter of FY25. The gross margin for the quarter was 32%, compared to 35%, in Q2 FY24.

The operating profit for the quarter stood at Rs 420 m. while the operating profit margin stood at 8%, versus 12%, YoY.

The bottom-line saw a decrease to Rs 190 m, while the net profit margin stood at 3.6%, versus 6.9%, in Q2 FY24.

IOL Chemicals & Pharmaceuticals Snapshot (2020-24)

	FY20	FY21	FY22	FY23	FY24
Revenue Growth (%)	12%	4%	11%	2%	-4%
Gross Profit Margin (%)	44%	44%	28%	30%	34%
Operating Profit Margin (%)	30%	30%	12%	10%	11%
Net Profit Margin (%)	19%	23%	8%	6%	6%
Return on Capital Employed (%)	68%	54%	18%	14%	12%
Return on Equity (%)	44%	35%	12%	9%	8%

Data Source: Ace Equity

Recently, the promotor holdings increased to 52.6% from 48.2%, in the previous quarter.

The management is committed to optimising market strategies, enhancing operational efficiencies, and expanding facilities to improve revenue and profitability.

It remains optimistic about future performance, citing potential recovery in pricing for key products and ongoing operational improvements.

For more information, you can have a look at the financial factsheet and quarterly results.

Conclusion

Rising promoter holdings can often be a positive indicator of confidence in a company's future, at the same time, it's important to remain cautious.

An increase in promoter stake does not always guarantee success or immediate growth. In some cases, promoters may increase their holdings to ward off hostile takeovers, or they might do so when they foresee limited liquidity in the market.

Moreover, the timing of these moves, such as during market downturns, can sometimes mask underlying challenges that are not immediately visible.

Investors should, avoid blindly following these trends. It's crucial to assess the company's overall fundamentals, business model, and growth potential, rather than relying solely on promoter stake movements.

While strong leadership is important, it should be weighed alongside broader market conditions and financial health.

Always stay conscious, and evaluate any investment opportunity based on its merit, using a comprehensive approach to make informed and balanced decisions.

Investors should also consider corporate governance as one of the criteria for due diligence before considering an investment.

Happy Investing.

Disclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. Learn more about our recommendation services here...